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What is already known about the topic?
•• Economic evidence in palliative care is important for making decisions regarding allocation of resources.
•• Economic research in palliative care is very limited.
•• Little is known about the range and extent of costs that are involved in palliative care provision and approaches used to 
capture these costs.
What this paper adds?
•• Components of palliative care costs are incurred within four broad domains: hospital care, community or home-based 
care, hospice care and informal care.
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Abstract
Background: It is important to understand the costs of palliative and end-of-life care in order to inform decisions regarding cost 
allocation. However, economic research in palliative care is very limited and little is known about the range and extent of the costs 
that are involved in palliative care provision.
Aim: To undertake a systematic review of the health and social care literature to determine the range of financial costs related to a 
palliative care approach and explore approaches used to measure these costs.
Design: A systematic review of empirical literature with thematic synthesis. Study quality was evaluated using the Weight of Evidence 
Framework.
Data sources: The databases CINAHL, Cochrane, PsycINFO and Medline were searched from 1995 to November 2015 for empirical 
studies which presented data on the financial costs associated with palliative care.
Results: A total of 38 papers met our inclusion criteria. Components of palliative care costs were incurred within four broad 
domains: hospital care, community or home-based care, hospice care and informal care. These costs could be considered from the 
economic viewpoint of three providers: state or government, insurers/third-party/not-for-profit organisations and patient and family 
and/or society. A wide variety of costing approaches were used to derive costs.
Conclusion: The evidence base regarding the economics of palliative care is sparse, particularly relating to the full economic costs of 
palliative care. Our review provides a framework for considering these costs from a variety of economic viewpoints; however, further 
research is required to develop and refine methodologies.
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•• Palliative care costs can be considered from the economic perspective of three providers: state or government, insurers/
third-party/not-for-profit organisations and patient and family and/or society.
•• A wide variety of costing approaches are used to derive costs; the majority are country specific.
Implications for practice, theory or policy
•• Research should prioritise evaluations of the full economic costs of palliative care, rather than discrete elements of care.
•• A framework for considering the components of costs to include in economic evaluations is presented and can be 
adapted for use in future research.
•• Further research is required to develop and refine economic methodologies, particularly those which enable interna-
tional comparisons to be made.
Introduction
Growing demands are being placed on palliative care ser-
vices as a result of population ageing, extending palliative 
care to people with non-cancer diagnoses and increasing 
death rates.1 As a result, palliative care must compete with 
other areas of care for finite resources, within a highly 
competitive funding environment, so that resources can be 
allocated effectively. It is therefore important to under-
stand the costs of palliative and end-of-life care in order to 
inform decisions regarding cost allocation.2 Health eco-
nomic evaluations are widely used to aid decision-making 
with respect to healthcare services, including palliative 
care. The analysis of the comparative costs of alternative 
treatments or healthcare programmes is common to all 
forms of economic evaluation. Two of the most fundamen-
tal questions to be considered in such evaluations are as 
follows: (1) which costs should be considered and (2) what 
is the viewpoint for the analysis (i.e. from whose perspec-
tive are costs to be considered).3
Within the context of palliative care, the first of these 
questions is complicated by the nature of palliative care 
interventions which commonly include multiple interacting 
elements,4 meaning the type and extent of costs are often 
complex. The second question is complicated by the wide 
range of individuals and organisations who are involved in 
funding palliative care and the overlap between these dif-
ferent providers.5 Palliative care is currently provided 
across three settings: hospital, community or home-based 
and hospice. Where palliative care is provided in hospices 
and specialist inpatient units, these are often co-funded 
through public healthcare systems or insurers and third-
party not-for-profit organisations. This means the adoption 
of a single ‘viewpoint’ for economic evaluation is often not 
appropriate. In addition, the financial costs to patients and 
family caregivers in palliative care are also significant, 
although this viewpoint has been particularly neglected and 
under-researched.6 Therefore, while well-evidenced and 
robust methods are available to guide economic evalua-
tions in health care,6 the most appropriate methods to 
undertake such evaluations in the context of palliative care 
are unknown, due in large part to the complexity inherent 
within the discipline. Perhaps as a consequence of these 
methodological challenges, economic research in palliative 
care is very limited. Indeed, a 2011 report from the UK 
Department of Health identified a ‘stunning lack of good 
data surrounding the costs for palliative care in England’ (p. 
9).5 The international evidence base regarding the eco-
nomic dimensions of palliative and end-of-life care provi-
sion is similarly sparse.7 A recent study from Canada noted 
the narrow viewpoint that the majority of economic analy-
ses have taken, highlighting that these have been limited to 
the measurement of publicly financed care without consid-
eration of the considerable costs faced by other stakehold-
ers, including patients and their families.8 These issues are 
further compounded by inconsistent definitions of pallia-
tive care internationally9 which have hampered attempts to 
identify exactly what constitutes a palliative care cost.
It was within this context that we identified a need to 
synthesise the existing literature in order to inform much 
needed consideration of which costs are potentially rele-
vant in economic evaluations of palliative care. Related to 
this, we also identified a need to consider the methods used 
to collect, and accurately cost, palliative care data with a 
view to providing methodological guidance for future eco-
nomic evaluations in palliative care. The aim of this article 
is therefore to undertake a systematic review of the health 
and social care literature to determine the range of finan-
cial costs related to a palliative care approach and explore 
approaches used to measure these costs.
Methods
In order to increase methodological rigour and transpar-
ency, and provide clarity around the research aim, the fol-
lowing definitions have been applied to the key concepts 
of the review. A palliative care approach is defined as a 
comprehensive package of palliative care incorporating 
specialist and/or generalist elements. For the purposes of 
this review, specialist palliative care is defined as care pro-
vided by professionals who have undergone recognised 
specialist palliative care training and generalist palliative 
care is defined as palliative care provided as part of stand-
ard clinical practice by any healthcare professional who is 
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not part of a specialist palliative care team. The range of 
costs is defined as all elements or components of health 
and social care expenditure related to a palliative care 
approach, including costs to patients and/or family mem-
bers and societal costs. Approaches to measuring costs are 
the methodological approaches used by researchers to cap-
ture and accurately cost economic data relating to a pallia-
tive care approach.
Four electronic databases (CINAHL, Cochrane, 
PsycINFO and Medline) were searched from 1995 to Nov 
2015. A search strategy was devised by the authors in con-
sultation with an information specialist (Table 1) and 
applied to title, keywords and abstracts. The search was 
limited to the last 20 years in recognition of the rapidly 
changing nature of funding and economic research and the 
limited relevance of research published pre-1995. The 
search comprised Medical Subject Headings (MeSH) and 
keywords related to the research question; an initial scop-
ing search was undertaken in order to refine the search 
strategy. Appropriate wildcards were inserted to search for 
word ending truncations where necessary. Reference lists 
of included studies were hand-searched. We also under-
took a comprehensive grey literature search of the follow-
ing organisations: Marie Curie Cancer Care, Nuffield 
Trust, UK Department of Health, National Institute for 
Clinical Excellence (NICE), Kings Fund, World Health 
Organization (WHO), National Audit Office (NAO), 
Office for National Statistics, National Council for 
Palliative Care, National End of Life Care Intelligence 
Network, American Academy of Hospice and Palliative 
Medicine and US Department of Health and Human 
Services. All searches were undertaken in November 2015.
Title and abstracts of all articles were screened by C.G. to 
identify those which met the study inclusion criteria. Study 
inclusion criteria can be found in Table 2. The original inten-
tion had been to restrict inclusion to papers which reported 
the full economic cost of palliative care, that is, the costs 
incurred in all settings related to the receipt of a palliative 
care approach, from the viewpoint of all providers including 
state/government, third-party payer and society and patient/
family. However, the scoping exercise identified very few 
papers that met this criterion so inclusion criteria were 
expanded to papers reporting costs in more than one setting 
or from the viewpoint of more than one provider.
Full texts of all included articles were independently 
screened by two of the four authors (C.G., M.G., C.I. and 
T.R.). Studies were again assessed to identify those which 
met the inclusion criteria. Where there was lack of consen-
sus, a third person acted as arbitrator. Details of included 
studies were extracted onto pre-defined forms.
The scoping search indicated that studies included in 
the full review would be likely to have diverse methodolo-
gies and significant heterogeneity; therefore, a thematic 
synthesis method was chosen in order to achieve transla-
tion between the results of the diverse studies.10 The the-
matic approach guided data extraction and was based on 
pre-defined categories relating to the research aim. Data 
Table 1. Search terms.
Palliative search terms  
MeSH Palliative care*
Terminal care
Terminally* ill
End of life care
Hospice
Additional keywords Life-limiting
Cost search terms  
MeSH Health expenditure
Health care costs
Costs and *cost analysis
Additional keywords Economic assessment
Economic evaluation
Economic implications
Resource utilization
Resource consumption
Health care utilization
Financial burden
Financial stress
Financial strain
MeSH: Medical Subject Headings.
Table 2. Inclusion and exclusion criteria.
Inclusion criteria Exclusion criteria
•• Papers must report costs of a palliative care approach 
(defined as a comprehensive package of care incorporating 
specialist and/or generalist elements).
•• Papers must report on full economic costs of palliative care, 
OR costs in more than one setting or from the viewpoint of 
more than one provider.
•• No restrictions on country of publication.
•• Original research (i.e. involving independent data collection) 
or literature reviews published in full.
•• Papers relating to adults (>18 years).
•• English language papers.
•• Papers published before 1995 (i.e. older than 20 years) OR 
papers where all the cost data were collected pre-1995.
•• Unpublished manuscripts, conference abstracts, posters 
and other empirical work not published in full.
•• Non-empirical articles, e.g., discussion papers, letters, 
editorials, commentaries.
•• Foreign language papers with no translation.
•• Papers only reporting on costs which relate to specific 
element of care or specific interventions, e.g., costs of 
advanced care planning/hospice care/home care.
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were extracted on the aim of the study, the design of the 
study, the components of costs, the data sources used and 
the methods used to collect cost data (Table 3).
Study quality was evaluated using the ‘Weight of 
Evidence Framework’, a method which structures quality 
and relevance appraisal in terms of three dimensions which 
involve both generic standards and review-specific assess-
ments.48 This approach to quality appraisal is particularly 
recommended for reviews involving studies with diverse 
methodologies where traditional method–specific check-
lists are not appropriate. The first dimension is the quality 
of execution of the study according to generic and accepted 
standards associated with that type of study (methodologi-
cal quality). The second dimension is the appropriateness 
of the study design for answering the review question 
(methodological relevance). The third dimension is how 
well matched the study is to the focus of the review (topic 
relevance). Studies were given a grading of 1–3 (low–
high) for each dimension and scores totalled. Studies with 
a total score of <4 were excluded.
Results
Search results are summarised in the adapted Preferred 
Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) flowchart in Figure 1. A total of 39 
papers met our inclusion criteria; however, one scored 
poorly on study quality (<4) and was subsequently 
excluded resulting in a final total of 38 papers (Table 3). 
All studies reported on a ‘palliative care approach’; how-
ever, the definition of palliative care differed across stud-
ies. The majority of studies were retrospective reviews of 
routine or claims’ data (n = 18) or prospective cohort stud-
ies (n = 10). Five studies were literature reviews, two were 
economic modelling studies, one a comparison group 
design, one a pilot study and one a methods development 
study. The majority of studies were from Canada (n = 11), 
the United States (n = 7) and the United Kingdom (n = 7). 
Quality scores of the included studies varied markedly, 
and only four received the top score of 9.13,14,18,47 In gen-
eral, low scores reflected the lack of high-quality data with 
which to estimate costs, rather than poor methodological 
choices or poor topic relevance.
Components of palliative care costs
Included studies reported a wide range of costs that were 
associated with providing a palliative care approach. 
However, only eight papers (based on data from five stud-
ies) collected data on the full economic cost of palliative 
care including costs incurred in all settings, from the view-
point of all providers.8,13,14,18–20,29,47 While some studies 
may have been conducted for a specific purpose which did 
not require full costs to be collected, the lack of compre-
hensive data on economic costs is concerning. Analysis of 
data from all included studies indicated that components of 
palliative care costs were incurred within four broad 
domains or settings: acute hospital care, community or 
home-based care, hospice care and informal care. These 
costs could be considered from the viewpoint of three pro-
viders: state or government, insurers/third-party/not-for-
profit organisations and patient and family and/or society. 
Viewpoint differed significantly depending on the health-
care funding system of the country in which the research 
took place. Table 4 provides a framework of the core cost 
components which are potentially relevant in economic 
evaluations of palliative care and the viewpoints from 
which these costs can be considered.
Hospital costs comprised all costs relating to inpatient, 
outpatient and ambulatory care in hospital. Hospital costs 
were the most commonly captured, reflecting the fact that 
hospital care tends to form the largest financial component 
of end-of-life care. Hospital costs included those relating 
to inpatient admissions, outpatient admissions, emergency 
room (ER) visits and ambulatory care. Some studies 
included country or culturally specific costs, for example, 
Chan et al.15 evaluated palliative care costs in hepatocel-
lular carcinoma in Hong Kong and included costs of 
Chinese medicines and herbal remedies. Only one study 
explicitly identified hospital overheads (building costs and 
capital depreciation, etc.) as a component of care costs, 
despite overheads accounting for a substantial 20% of the 
cost per patient per day in this study.40 Community or 
home-based care costs comprised all costs generated 
through care based in the community or in the patients’ 
own home. These costs were numerous and there was sig-
nificant heterogeneity across studies in the nature of these 
costs, most notably between different countries. These 
costs included visits and associated costs from general 
practitioners (GP’s)/family physicians and community 
nurses, and also a wide range of additional ancillary costs 
such as those incurred from social services, support from 
allied health professionals and care provided in a range of 
day care and residential settings. Only one study specifi-
cally included costs of mental health care.26 Hospice care 
costs comprised all costs relating to inpatient and outpa-
tient hospice care. They were broadly similar to those 
related to hospital care, but were usually recorded less 
comprehensively, perhaps as a consequence of the range 
and complexity of providers involved in funding hospice 
care and the differential definitions of hospice across the 
world. Costs incurred by patients and their families were 
included in only a small number of studies.8,13–15,18–20,29,47 
Some of these costs represented direct costs to patients and 
family (i.e. direct outlays of money or out-of-pocket costs); 
however, others were assumed or indirect costs (i.e. 
income lost through illness or caregiving, or caregiver 
time costs). None of the included studies attempted to cap-
ture costs relating to lost productivity from the perspective 
of employers.
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Description of costing approaches used to 
derive costs
A wide variety of costing approaches were used to derive 
costs. These approaches varied significantly between dif-
ferent countries, largely dependent on the differing fund-
ing mechanisms for health care. For example, studies from 
the United States commonly utilised Medicare and 
Medicaid insurance claims’ data to calculate costs relating 
to palliative care.29,16,27,34,44,45 Medicare and Medicaid are 
national social insurance programmes which provide 
health coverage in the United States. Using Medicare or 
Medicaid data to calculate costs has the advantage that 
claims’ data represent the true cost to the insurer, and not a 
proxy or derived cost. However, it should be acknowl-
edged that while claims’ data provides an accurate cost 
estimate, this only represents a narrow viewpoint for anal-
ysis as it fails to capture costs to third-party providers, 
patients/families or society. The apparent complexity of 
capturing truly comprehensive cost data is reflected in the 
fact that only one study from the United States attempted 
to describe costs that included both Medicare and non-
Medicare expenditure.29
In contrast, studies from the United Kingdom calcu-
lated costs using more diverse methodologies, due to the 
complex arrangement of commissioned publicly funded 
health services. For example, UK studies generally calcu-
lated hospital costs on the basis of national ‘tar-
iffs’.11,15,17,24,38 A tariff is the cost attached to a grouping of 
healthcare units of similar resource need (a currency) and 
represents the cost paid by the commissioner not the actual 
cost to the healthcare provider.50 Approaches to deriving 
community and hospice costs were based on data which 
are generally considered to be even less accurate. UK com-
munity costs were commonly derived from nationally 
available ‘Unit Costs of Health and Social Care’. These 
unit cost estimates are calculated by the Personal Social 
Services Research Unit drawing together a range of rou-
tine data and research to provide estimates of national unit 
costs.51 Estimates of the cost of hospice care in the United 
Kingdom are perhaps the most difficult to determine, with 
National Health Service (NHS) and voluntary sector pro-
viders funded in a variety of different ways. Georghiou 
and Bardsley22 attempted to calculate hospice costs based 
on national data but acknowledged ‘our estimate of the 
costs of hospice care at the end of life was based on crude 
Figure 1. PRISMA diagram summarising search results.
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Table 4. Framework outlining perspectives of economic evaluations in palliative care and components of their related costs.
Perspective Types of cost Components of cost References
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Hospital Inpatient hospital admissions/bed days 8, 11–21, 23–26, 28–34, 40, 42–47
Personnel costs 13, 14, 40, 46
Medical supplies, equipment and aids, etc. 8, 13, 14, 29
Inpatient procedures (surgery, chemo, etc.) 13, 14, 17, 29
Investigations, laboratory and diagnostic costs 8, 13–15, 17, 29, 43
Drugs and medications 8, 12–15, 40, 46
Outpatient hospital admissions 8, 12, 13, 15–17, 21, 29, 30, 32–35, 38, 47
ER visits 8, 12–14, 16, 21, 23, 30, 32, 43, 46, 47
Ambulatory costs and transport 8, 13, 14, 18–20, 43, 44
Hospital day care 12–14, 17
Outpatient procedures (chemotherapy, etc.) 12–14, 43
Chinese and herbal medicines 15
Overhead costs (building costs and capital 
depreciation)
40
Palliative care unit admission 38, 46, 49
Palliative care outpatient clinics 24, 38, 49
Community/
home-based
GP/family physician surgery visits
Medical and nursing home visits (GP, DN, etc.)
Allied health home visits (physio, OT, mental health)
Other home visits (social services, home care, other 
carers)
Drugs and medications
Medical equipment, aids and adaptations
Day care services
Stays in long-term care facilities, care homes, nursing 
homes, skilled nursing facilities
Transportation
Diagnostic tests, laboratory costs
Personal support (bathing, feeding, dressing, home help)
Other social services (meals on wheels, etc.)
Nutritional counselling
Dental services
Communication costs
Residential respite care and rehabilitation
Overhead costs
Direct payments made to users so they can ‘buy’ their 
own services
8, 13, 14, 17, 21, 23–26, 31, 34, 39–41
8, 13, 14, 17, 21, 24, 26, 29, 30, 38, 40
8, 13, 14, 26, 29, 30, 38
8, 11, 13, 14, 17, 26, 29, 30, 31, 33, 45
8, 13, 14, 18–21, 24, 29, 31, 34, 40, 44
8, 11, 13, 14, 18–20, 45
12–14
8, 11, 18, 21, 28, 29, 32, 34, 44–46
13, 14, 18–20, 40
8, 13, 14, 31
13, 14, 26, 31
11, 26
31
29
40
11, 46
40
11
Hospice and 
specialist 
palliative care
Inpatient hospice stays/bed days 8, 13–16, 21, 29, 30, 32, 34, 45
Personnel costs 13, 14
Medical supplies 13, 14, 31
Inpatient procedures 13, 14
Investigations, laboratory and diagnostic costs 13, 14
Drugs and medications 13, 14, 31
Equipment and aids 13, 14, 31
Outpatient appointments and clinics 13, 14, 16
Home hospice 12–14
Home visits from specialist palliative care 13, 14, 21, 24
Start-up costs, e.g., for new community palliative care 
nursing service
40
Informal care Home caregivers 8, 13, 14
Household help 13, 14
Equipment, aids, home adaptations 8, 13–15
Medications 8, 13, 14
Insurance payments 8, 13, 14, 29
Travel and accommodation expenses 8, 13, 14
Out-of-pocket expenses (parking, food/drink) 8, 13, 14, 18–20, 29, 47
Income lost from work 8, 13–15, 18–20
Caregiver time costs 8, 13, 14, 18–20, 47
Co-payments, e.g., shared with insurer/other 33
ER: emergency room; GP: general practitioner; OT: occupational therapist.
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aggregated measures of national hospice care use’ (p. 29). 
In addition to significant national differences in the way 
costs were calculated, differences were sometimes noted at 
a regional level. In Canada, for instance, unit costs for hos-
pitalisation are agreed regionally by federal health authori-
ties and differ, for example, between Ontario47 and 
Alberta18 meaning different costing approaches are 
required even within a single country.
Approaches to capturing costs incurred by patients and 
their families were particularly complex as these costs are 
split between direct outlays of money (out-of-pocket costs) 
and indirect or assumed costs related to lost income from 
work or caregiver time. The collection of data on direct 
costs usually relied on patient or caregiver self-report of 
actual costs,8,13–15,18–20,29,47 an approach that provides a 
‘true’ cost but is susceptible to error and recall bias. In 
cases where participants were unable to recall an actual 
cost, Dumont et al.18 obtained an estimate by taking the 
average cost of the same item as provided by other partici-
pants. Approaches to capturing assumed or indirect costs 
were more complex. Chai et al.,13,14 Yu et al.47 and 
Guerriere and Coyte8 used the human capital approach 
which assigns a monetary value to caregiver time using 
costs estimated from census data on average earnings. 
Dumont et al.18 used a similar approach whereby caregiver 
time costs were obtained based on an average monetary 
value attributed to household work in Canada for men and 
women.
Description of data collection tools
In general, the tools used to collect cost data were devel-
oped on an ad hoc basis for individual studies and were not 
standardised or validated tools. For example, Dumont 
et al.18 developed their study questionnaire through the 
Delphi procedure and generated questions in line with the 
validated Canadian Community Health Survey performed 
by Statistics Canada. Other authors extracted administra-
tive or claims’ data directly into study-specific proto-
cols.12,29,27,34,44,45 The study by Guerriere and Coyte8 
proposed the use of a standardised framework for captur-
ing costs in Canada: the Ambulatory and Home Care 
Record (AHCR). This tool was designed to capture com-
prehensive costs and was subsequently validated and used 
in the studies by Chai et al.13,14 and Yu et al.47 The study by 
Mosoiu et al.40 also proposed a standardised costing frame-
work for Romania;, however this was restricted to cost ele-
ments to the public healthcare system and did not include 
any costs from the viewpoint of third party or patient/fam-
ily and society.
Discussion
This systematic review explored which costs are poten-
tially relevant in economic evaluations of palliative care 
and identified approaches to collecting, and accurately 
costing, palliative care data. The findings suggest that a 
wide range of costs can be incurred during the palliative 
phase, costs that can be considered in four key domains: 
hospital care, community or home-based care, hospice 
care and informal care. Findings also suggest three key 
provider viewpoints to consider in economic analyses: 
state or government, insurers/third-party/not-for-profit 
organisations and patient and family and/or society. 
However, few studies in this review attempted to capture 
the full economic cost of palliative care with only eight 
papers collecting comprehensive cost data.8,13,14,18–20,29,47 
Various reasons may account for this. Studies undertaken 
for specific organisations such as Regulatory Authorities 
may be required to conform to a specific perspective. This 
will vary on a national basis. For instance, in England, the 
National Institute for Health and Care Excellence (NICE)52 
states that ‘productivity costs and costs borne by people 
using services and carers that are not reimbursed by the 
NHS or social services should not usually be included in 
any analyses. That is, a societal perspective will not nor-
mally be used’. It may also be reasonable to exclude cer-
tain costs if they are known to have little impact on the 
overall results. However, economic evaluations should be 
explicit about what has been included and excluded and 
provide justification for this.
The collection of data which captures the full economic 
cost of palliative care is an urgent priority. This has been 
highlighted in a recent report from the UK National End of 
Life Care Programme53 which noted that despite the exist-
ence of a range of costing information, ‘there are no robust, 
agreed costs of end of life care’. A necessary prerequisite to 
calculating the full economic cost of palliative care is an 
understanding of the potential range of costs to be included 
in any economic analysis. Our review provides an overview 
of the core cost components that are potentially relevant 
within each of four key domains and a framework for con-
sidering these costs from a variety of economic viewpoints. 
The framework identifies core cost components as identi-
fied by this review but is unlikely to be comprehensive and 
therefore should be considered a basic framework from 
which to build on. The range of cost components and the 
viewpoint from which analyses are undertaken are also nec-
essarily context- and country specific. For example, in 
countries with comprehensive health coverage, the majority 
of hospital costs will be covered by state or third-party pro-
viders, while in low-income countries without comprehen-
sive health coverage these costs will often be covered by 
patients and their families. Our framework is designed to be 
wide in scope and adaptable, with the intention that research-
ers from countries with differing funding mechanisms for 
palliative care can select the most appropriate cost compo-
nents and viewpoints for their needs. All the studies in this 
review were from upper-middle or high-income coun-
tries,54 and there is a notable absence of data from lower 
income economies. Therefore, our proposed framework is 
likely to require further refinement to be suitable for 
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research in low-income countries. In countries where multi-
ple providers (agencies) are involved in the delivery of pal-
liative care, there is likely to be a range of cost, resource and 
other outcomes which are potentially relevant to any evalu-
ation. In these situations, multi-agency cost consequence 
analysis in which all the impacts of an intervention across 
different sectors (e.g. hospital care, community care, social 
care) are reported in a disaggregated form may be helpful.55 
This type of analysis highlights the distribution of effects 
across the system and allows potential economic barriers 
and perverse incentives to be managed.
Of particular note was the lack of studies in this review 
which explored costs from the viewpoint of patient and 
family, related to informal care. This is despite mounting 
evidence which highlights both the magnitude of these 
costs and the significant impact of the costs in terms of 
health and wel-lbeing.6,56,57 In a context of limited 
resources and growing demand for services, family car-
egivers are expected to shoulder an increasing burden of 
responsibility for palliative care provision.58 The associ-
ated financial costs to patient and family are significant, 
and it is imperative that these costs are accounted for as 
part of any full economic costing in palliative care. Our 
review findings support a recent UK report on the costs of 
dying at home which noted ‘economic analyses should 
reflect the cost to family members of caring, and should 
consider how savings to the state can be harnessed to sup-
port carers to continue to care at home’.58 The approaches 
used to capture cost data from patient and families are 
complex and may deter researchers from attempting to 
estimate these costs. Evidence suggests that these costs 
include both direct (out-of-pocket) and indirect costs (carer 
time costs, lost income, etc.).57 While estimates of direct 
costs to patient and family are relatively easy to capture 
using self-report measures such as those employed by 
Dumont et al.18–20 and Chai et al.,13,14 the collection of indi-
rect cost data is more complex. The human capital approach 
is often used for estimating time lost from employment;59 
this approach applies the current average wages by age and 
sex categories to lost labour market time. Caregiver time 
lost from other household or leisure activities can be val-
ued using replacement costs based on the average hourly 
wage of a homemaker.13,14 The use of methods such as 
these enables a consistent approach to the collection of 
patient and family data which are easily adapted by coun-
try and/or region. However, it should be acknowledged 
that these approaches are subject to limitations. The human 
capital approach is subject to market imperfections such as 
gender, race and other types of discrimination.60 In addi-
tion, both approaches generate crude population estimates 
of cost rather than the true cost to an individual. Finally, it 
should be noted that none of the studies in this review 
attempted to capture productivity costs, that is, productiv-
ity losses to employers. These costs should be acknowl-
edged as an additional potential component of cost that 
could be considered under the societal perspective.
A wide range of approaches to capturing and deriving 
costs were identified in the included studies. Most 
approaches focused on hospital costs, which is not surpris-
ing given that inpatient hospital care is consistently identi-
fied as the most costly component of palliative care.16,18,24,29 
Whatever approach is used, it is important that both unit 
quantities and costs/prices should be defined to ensure 
transparency. Approaches to capturing costs were gener-
ally specific to the country and healthcare funding system 
in which the study took place. The majority of the 
approaches are derived from North American literature; 
this presents a challenge to researchers from other coun-
tries as economic evidence does not transfer easily between 
countries or between different healthcare systems.49 For 
example, it is difficult to envisage how an approach solely 
utilising insurance claims’ data could be usefully adapted 
to a country with a largely state-funded healthcare system. 
Despite this, international comparisons on the economics 
of health provision clearly have value for gaining insight 
into the cost-effectiveness of various health systems and 
models of health care. Indeed, in recent years, the emer-
gence of high quality and comparable international health 
and economic data in the field of ageing has allowed eco-
nomic modelling through an international comparative 
lens.49 Therefore, while significant challenges still exist 
with the translation of health data between countries and 
health systems, there is clear potential for benefit if these 
challenges can be overcome.
Limitations
Searches were limited to English language articles so we 
cannot be completely confident that our searches were 
comprehensive. The majority of grey literature searches 
were from UK and North American sources; therefore, 
data from other countries may have been missed. Studies 
included in the review had variable rigour and relevance 
and generalisations should be considered with caution. 
The majority of studies in the review only included cancer 
patients, and findings may not be generalisable across 
other conditions.
Conclusion
Our review findings point to an urgent need for further 
research on the economic costs of palliative care. Research 
which captures the full economic cost should be prioritised 
in order to gain insight into the inter-relationships between 
different cost domains and different provider viewpoints 
and could build on the cost framework proposed here. 
Methodological developments are also required to generate 
novel approaches to data collection which provide more 
accurate cost estimates. These may include economic mod-
elling approaches such as those which have recently been 
used to estimate costs of care in cancer.61 While some 
approaches will be country- or region specific, the value of 
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internationally comparative economic data is significant 
and should drive further methodological developments in 
this area.
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